accountof the Alzheimer's drug Aricept claiming that the risks far exceed the benefits. The drug, made by Pfizer and Elsai, is currently approved at doses of 5 to 10 milligrams for patients with mild to moderate Alzheimer's disease and doses of 10 to 23...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Watchdog Calls for Ban on Alzheimer's Drug Dosage
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account